Cite
HARVARD Citation
Botla, V. et al. (2017). Molecular Engineering of Tetracyclic 2, 3‐Dihydro‐1H‐benzo[2, 3]‐benzofuro[4, 5‐e][1, 3]oxazine Derivatives: Evaluation for Potential Anticancer Agents. Archiv der Pharmazie. 350 (10), p. n/a. [Online].